Acorda, Biogen gain on MS drug update By: MarketWatch May 20, 2011 at 12:58 PM EDT Shares of Acorda, Biogen and Elan rise amid a declining market after European regulators move toward approving their MS drug Fampyra. Read More >> Related Stocks: Acorda Therapeutics Biogen Idec Vivus Inc